Ferric carboxymaltose in patients with restless legs syndrome and nonanemic iron deficiency: A randomized trial

Background: Compromised iron status is important in restless legs syndrome pathophysiology. We compared the efficacy and tolerability of ferric carboxymaltose (single intravenous dose) versus placebo for restless legs syndrome treatment in iron‐deficient nonanemic patients. Methods: Patients with mo...

Descripción completa

Detalles Bibliográficos
Autores principales: Trenkwalder, Claudia, Winkelmann, Juliane, Oertel, Wolfgang, Virgin, Garth, Roubert, Bernard, Mezzacasa, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5655783/
https://www.ncbi.nlm.nih.gov/pubmed/28643901
http://dx.doi.org/10.1002/mds.27040

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5655783/
https://www.ncbi.nlm.nih.gov/pubmed/28643901
http://dx.doi.org/10.1002/mds.27040

Ejemplares similares